Total Payments
$33,512
2024 Payments
$7,007
Companies
9
Transactions
53
Medicare Patients
1,644
Medicare Billing
$500,344

Payment Breakdown by Category

Consulting$29,323 (87.5%)
Travel$3,238 (9.7%)
Food & Beverage$726.29 (2.2%)
Education$124.60 (0.4%)
Other$100.00 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $29,323 13 87.5%
Travel and Lodging $3,238 12 9.7%
Food and Beverage $726.29 21 2.2%
Education $124.60 6 0.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100.00 1 0.3%

Top Paying Companies

Company Total Records Latest Year
United Therapeutics Corporation $12,756 29 $0 (2023)
Vertex Pharmaceuticals Incorporated $9,405 2 $0 (2022)
Merck Sharp & Dohme LLC $7,417 8 $0 (2024)
VIVUS LLC $2,570 1 $0 (2021)
Baxter Healthcare $550.00 2 $0 (2021)
Bayer Healthcare Pharmaceuticals Inc. $392.80 6 $0 (2024)
GlaxoSmithKline, LLC. $230.00 1 $0 (2018)
Actelion Pharmaceuticals US, Inc. $159.60 2 $0 (2023)
Gilead Sciences, Inc. $31.91 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,007 8 Merck Sharp & Dohme LLC ($6,807)
2023 $5,968 14 United Therapeutics Corporation ($5,322)
2022 $14,508 13 Vertex Pharmaceuticals Incorporated ($9,000)
2021 $5,384 10 VIVUS LLC ($2,570)
2020 $225.00 2 Bayer HealthCare Pharmaceuticals Inc. ($125.00)
2019 $31.91 2 Gilead Sciences, Inc. ($31.91)
2018 $371.69 3 GlaxoSmithKline, LLC. ($230.00)
2017 $17.52 1 Bayer HealthCare Pharmaceuticals Inc. ($17.52)

All Payment Transactions

53 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/28/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $5,490.00 General
10/28/2024 Merck Sharp & Dohme LLC Travel and Lodging Cash or cash equivalent $195.46 General
10/28/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $16.82 General
10/17/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Travel and Lodging In-kind items and services $694.27 General
Category: CARDIOVASCULAR
10/16/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Travel and Lodging In-kind items and services $388.43 General
Category: CARDIOVASCULAR
10/10/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Education In-kind items and services $10.85 General
Category: CARDIOVASCULAR
09/23/2024 Bayer Healthcare Pharmaceuticals Inc. Adempas (Drug) Consulting Fee Cash or cash equivalent $200.00 General
Category: Cardio-pulmonary
07/12/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Education In-kind items and services $10.85 General
Category: CARDIOVASCULAR
12/11/2023 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $610.00 General
08/22/2023 United Therapeutics Corporation TYVASO (Drug) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $103.17 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $60.95 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $50.35 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $27.83 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $23.94 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $23.85 General
Category: PAH
08/04/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $6.04 General
Category: PAH
08/03/2023 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $261.06 General
Category: PAH
08/03/2023 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $50.15 General
Category: PAH
08/03/2023 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $31.00 General
Category: PAH
07/31/2023 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $483.90 General
Category: PAH
02/14/2023 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $35.60 General
Category: Cardiology
11/21/2022 United Therapeutics Corporation Consulting Fee Cash or cash equivalent $4,200.00 General
10/28/2022 United Therapeutics Corporation Travel and Lodging In-kind items and services $115.31 General
10/28/2022 United Therapeutics Corporation Food and Beverage In-kind items and services $68.88 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 519 995 $776,210 $145,187
2022 10 455 862 $653,550 $134,471
2021 9 343 737 $581,865 $107,630
2020 8 327 719 $645,674 $113,056
Total Patients
1,644
Total Services
3,313
Medicare Billing
$500,344
Procedure Codes
46

All Medicare Procedures & Services

46 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 128 316 $395,000 $65,947 16.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 76 145 $63,800 $18,039 28.3%
99292 Critical care, each additional 30 minutes Facility 2023 62 148 $92,500 $15,975 17.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 63 112 $54,600 $13,756 25.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 58 64 $51,200 $10,878 21.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 28 88 $36,080 $10,498 29.1%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 14 14 $9,380 $2,184 23.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 14 14 $9,540 $2,159 22.6%
93451 Insertion of tube in right heart chambers for measurement Facility 2023 13 13 $7,930 $1,587 20.0%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2023 12 12 $5,400 $1,583 29.3%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 17 20 $40,000 $1,495 3.7%
36620 Insertion of artery tube for blood sampling or infusion through skin Facility 2023 12 16 $8,800 $649.76 7.4%
76937 Ultrasonic guidance for blood vessel access Facility 2023 22 33 $1,980 $436.59 22.0%
99291 Critical care, first 30-74 minutes Facility 2022 115 285 $356,250 $63,272 17.8%
99292 Critical care, each additional 30 minutes Facility 2022 63 134 $83,750 $15,008 17.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 63 101 $44,440 $13,596 30.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 51 58 $46,400 $11,528 24.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 23 112 $45,920 $11,300 24.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 44 63 $31,920 $8,529 26.7%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2022 14 15 $6,750 $2,048 30.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 12 12 $8,360 $2,002 23.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 11 11 $7,370 $1,943 26.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 23 $8,210 $1,818 22.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 15 21 $6,510 $1,817 27.9%
93451 Insertion of tube in right heart chambers for measurement Facility 2022 11 11 $6,710 $1,408 21.0%

About Dr. Hooman Poor, MD

Dr. Hooman Poor, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1982863502.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hooman Poor, MD has received a total of $33,512 in payments from pharmaceutical and medical device companies, with $7,007 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($29,323).

As a Medicare-enrolled provider, Poor has provided services to 1,644 Medicare beneficiaries, totaling 3,313 services with total Medicare billing of $500,344. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.

Practice Information

Products in Payments

  • TYVASO (Drug) $7,078
  • WINREVAIR (Biological) $1,104
  • Fluid Systems - Drug Delivery Systems (Device) $550.00
  • Adempas (Drug) $378.49
  • ANORO (Drug) $230.00
  • ORENITRAM (Drug) $70.31
  • UPTRAVI (Drug) $35.60
  • Letairis (Drug) $31.91
  • Verquvo (Drug) $14.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in New York